Release Date: 29/08/17 10:13 Summary: Appendix 4D FY17 Half Yearly Report and Accounts Price Sensitive: Yes Download Document 524.08KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market